These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23300836)

  • 1. Multi-analyte network markers for tumor prognosis.
    Kim J; Gao L; Tan K
    PLoS One; 2012; 7(12):e52973. PubMed ID: 23300836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the epigenetics of glioblastomas.
    Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
    Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature.
    Chiang JH; Cheng WS; Hood L; Tian Q
    OMICS; 2014 May; 18(5):310-23. PubMed ID: 24601786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
    Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X
    Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme.
    Martinez R; Schackert G; Esteller M
    J Neurooncol; 2007 Apr; 82(2):133-9. PubMed ID: 17048097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian variable selection with graphical structure learning: Applications in integrative genomics.
    Kundu S; Cheng Y; Shin M; Manyam G; Mallick BK; Baladandayuthapani V
    PLoS One; 2018; 13(7):e0195070. PubMed ID: 30059495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma.
    He X; Zhang S; Chen J; Li D
    Cancer Med; 2019 May; 8(5):2031-2040. PubMed ID: 30848102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma.
    Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q
    Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics reveals the novel co-expression signatures in early brain development for prognosis of glioblastoma multiforme.
    Yu X; Feng L; Liu D; Zhang L; Wu B; Jiang W; Han Z; Cheng S
    Oncotarget; 2016 Mar; 7(12):14161-71. PubMed ID: 26895104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers.
    Lan Z; Li X; Zhang X
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.
    Xiu J; Piccioni D; Juarez T; Pingle SC; Hu J; Rudnick J; Fink K; Spetzler DB; Maney T; Ghazalpour A; Bender R; Gatalica Z; Reddy S; Sanai N; Idbaih A; Glantz M; Kesari S
    Oncotarget; 2016 Apr; 7(16):21556-69. PubMed ID: 26933808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types.
    Mathios D; Hwang T; Xia Y; Phallen J; Rui Y; See AP; Maxwell R; Belcaid Z; Casaos J; Burger PC; McDonald KL; Gallia GL; Cope L; Kai M; Brem H; Pardoll DM; Ha P; Green JJ; Velculescu VE; Bettegowda C; Park CK; Lim M
    Int J Cancer; 2019 Dec; 145(12):3425-3435. PubMed ID: 31373686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification.
    Wenger A; Ferreyra Vega S; Kling T; Bontell TO; Jakola AS; Carén H
    Neuro Oncol; 2019 May; 21(5):616-627. PubMed ID: 30668814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA methylome of glioblastoma multiforme.
    Martinez R; Esteller M
    Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
    Dong C; Fan W; Fang S
    J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
    Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
    DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
    Mukherjee S
    Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of CPS1 in glioblastoma multiforme.
    Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z
    Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.